Find Clinical Trials | Cedars-Sinai

12 results found

Multiple Myeloma

Elranatamab in Combination With Other Anti-Cancer Treatments in Multiple Myeloma

The purpose of the study is to learn whether an investigational drug called nirogacestat can improve the effectiveness of another drug, elranatamab, in treating patients with multiple myeloma who have had their disease relapse. Elranatamab is ...

Multiple Myeloma

Low-Dose Palliative Radiotherapy in Bone Metastases from Multiple Myeloma

The purpose of this study is to evaluate whether pain relief can be achieved using only 1-2 radiation treatments to a painful bone lesion in patients with multiple myeloma (MM). Bone disease is common in ...

Multiple Myeloma

Iberdomide Maintenance Therapy Following CAR-T in Multiple Myeloma

This study focuses on individuals who have multiple myeloma that has relapsed (meaning it has come back after prior therapy) and/or refractory (resistant to certain therapies). The purpose of the study is to determine whether ...

Multiple Myeloma

Janssen Scientific Affairs, LLC, 68284528MMY4006, EAP, openl,MM, ciltacabtagene autoleucel OOS,

Primary Objective: The purpose of this expanded access program (EAP) is to provide ciltacabtagene autoleucel (cilta-cel) that does not meet the commercial release specifications of CARVYKTI and is not available via the local health care ...

Multiple Myeloma

ABBV-383 Compared With Standard Available Therapies in Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called ABBV-383 in people with relapsed or refractory multiple myeloma (multiple myeloma that has come back or did not ...